Skip to main content

You must have JavaScript enabled in order to access this part of the site. Please enable JavaScript and then reload this page in order to continue.

Home Health and Hospice Agencies CLIA Waiver Information

Last updated on

As COVID-19 testing becomes more available, it will be important for home health and hospice agencies to apply for a CLIA waiver as part of their overall preparedness efforts.

Unless your agency currently provides laboratory services in accordance with 26 TAC §558.284, you will need to apply for a Clinical Laboratory Improvement Amendment waiver to offer and perform certain COVID-19 testing for employees and clients directly.

To obtain a CLIA Waiver for COVID-19 point of contact testing using a rapid POC diagnostic testing device, complete Form CMS-116 (PDF) available on the CMS CLIA website or on the HHSC Health Care Facilities Regulation - Laboratories webpage found under the Application header.

Applications must be emailed to the HHSC regional CLIA licensing group at HHSC HCF Regulation – Laboratories webpage.